research in the field? Illustrate how quality improvement and quality improvement research can impact greater production use of plant and human assets, lead to product differentiation and branding, generate revenue enhancements, improve cost structure, and impact other core operational goals to create competitive advantages.

  • What are the characteristics of an ideal enterprise culture and effective governance orientation that promote and accelerate improvement in quality and quality improvement research?

  • What are the business disciplines and support structures that are essential for leadership to fully exploit the economic/financial benefits of quality improvement and quality improvement research?

  • In order to drive organizational improvement from validated, well-researched data, how do you effectively measure and evaluate progress against quality improvement targets and quantify returns on investments made? What are the essential components of such a system?

  • Are there models in other industries such as aviation and nuclear power wherein the drive for quality has transformed product outcomes and customer/public safety? How do we learn from them?

11:30 am

Working Lunch

12:30 pm

Session 2: The Role of Policy Makers

 

Carolyn Clancy, Agency for Healthcare Research and Quality

Barnett S. Kramer, National Institutes of Health

 

Moderator: Denise Cardo, Centers for Disease Control and Prevention

  • Issues to Be Addressed:

    • What are the fundamental public policy features and objectives that will lead to a transformational improvement in the quality and economic viability of our health care system?



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement